Skip to content

Press

  1. Home
  2. Press

Publication date:

15/04/2021

Press release title:

HIPRA plans to produce 400 million doses of its SARS-CoV-2 HIPRA vaccine during 2022

Publication date:

11/12/2020

Press release title:

HIPRA takes a firm step towards human health with research and manufacture of a COVID-19 vaccine

Publication date:

19/06/2020

Press release title:

The Girona Health Region has already analyzed more than 30,000 PCR samples, 16% of which are positive

Publication date:

01/06/2020

Press release title:

The collaboration between HIPRA and the health authorities allows over 30,000 PCR tests to be analysed in record time

Publication date:

08/04/2020

Press release title:

Transferring part of the coronavirus diagnostic testing process to HIPRA increases the number of samples analyzed per day and reduces response time

Publication date:

20/03/2020

Press release title:

The Animal Health Company HIPRA makes its biotechnology facilities and equipment available to the health authorities

Publication date:

8/04/2020

Press release title:

El traslado a HIPRA de parte del proceso de las pruebas diagnósticas del coronavirus permite aumentar el número de muestras analizadas por día y reducir el tiempo de respuesta